ID CA2D1_HUMAN Reviewed; 1103 AA. AC P54289; Q17R45; Q9UD80; Q9UD81; Q9UD82; DT 01-OCT-1996, integrated into UniProtKB/Swiss-Prot. DT 03-NOV-2009, sequence version 3. DT 27-MAR-2024, entry version 212. DE RecName: Full=Voltage-dependent calcium channel subunit alpha-2/delta-1; DE AltName: Full=Voltage-gated calcium channel subunit alpha-2/delta-1; DE Contains: DE RecName: Full=Voltage-dependent calcium channel subunit alpha-2-1; DE Contains: DE RecName: Full=Voltage-dependent calcium channel subunit delta-1; DE Flags: Precursor; GN Name=CACNA2D1; Synonyms=CACNL2A, CCHL2A, MHS3; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY. RX PubMed=1309651; DOI=10.1016/0896-6273(92)90109-q; RA Williams M.E., Feldman D.H., McCue A.F., Brenner R., Velicelebi G., RA Ellis S.B., Harpold M.M.; RT "Structure and functional expression of alpha 1, alpha 2, and beta subunits RT of a novel human neuronal calcium channel subtype."; RL Neuron 8:71-84(1992). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC TISSUE=Cerebellum; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP NUCLEOTIDE SEQUENCE [MRNA] OF 528-648 (ISOFORMS 1; 2; 3; 4 AND 5), TISSUE RP SPECIFICITY, AND ALTERNATIVE SPLICING. RC TISSUE=Neuroblastoma; RX PubMed=8107964; DOI=10.1016/0028-3908(93)90004-m; RA Brust P.F., Simerson S., McCue A.F., Deal C.R., Schoonmaker S., RA Williams M.E., Velicelebi G., Johnson E.C., Harpold M.M., Ellis S.B.; RT "Human neuronal voltage-dependent calcium channels: studies on subunit RT structure and role in channel assembly."; RL Neuropharmacology 32:1089-1102(1993). RN [5] RP GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-136; ASN-324 AND ASN-675. RC TISSUE=Plasma; RX PubMed=16335952; DOI=10.1021/pr0502065; RA Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J., RA Smith R.D.; RT "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, RT hydrazide chemistry, and mass spectrometry."; RL J. Proteome Res. 4:2070-2080(2005). RN [6] RP GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-348; ASN-475 AND ASN-824. RC TISSUE=Liver; RX PubMed=19159218; DOI=10.1021/pr8008012; RA Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; RT "Glycoproteomics analysis of human liver tissue by combination of multiple RT enzyme digestion and hydrazide chemistry."; RL J. Proteome Res. 8:651-661(2009). RN [7] RP INTERCHAIN DISULFIDE BOND, AND SUBUNIT. RX PubMed=22054663; DOI=10.1016/j.ceca.2011.10.002; RA Calderon-Rivera A., Andrade A., Hernandez-Hernandez O., RA Gonzalez-Ramirez R., Sandoval A., Rivera M., Gomora J.C., Felix R.; RT "Identification of a disulfide bridge essential for structure and function RT of the voltage-gated Ca(2+) channel alpha(2)delta-1 auxiliary subunit."; RL Cell Calcium 51:22-30(2012). RN [8] RP STRUCTURE BY ELECTRON MICROSCOPY (3.0 ANGSTROMS) OF 38-361 IN COMPLEX WITH RP HUMAN CAV2.2/CACNA1B AND BETA-3 SUBUNIT IN PRESENCE AND ABSENCE OF THE RP OMEGA-CONOTOXIN MVIIA, DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-92; RP ASN-184; ASN-348; ASN-468; ASN-613; ASN-781 AND ASN-895. RX PubMed=34234349; DOI=10.1038/s41586-021-03699-6; RA Gao S., Yao X., Yan N.; RT "Structure of human Cav2.2 channel blocked by the painkiller ziconotide."; RL Nature 596:143-147(2021). RN [9] RP VARIANT DEE110 ASP-209, CHARACTERIZATION OF VARIANT DEE110 ASP-209, RP FUNCTION, SUBCELLULAR LOCATION, AND INVOLVEMENT IN DEE110. RX PubMed=35293990; DOI=10.1093/brain/awac081; RA Dahimene S., von Elsner L., Holling T., Mattas L.S., Pickard J., Lessel D., RA Pilch K.S., Kadurin I., Pratt W.S., Zhulin I.B., Dai H., Hempel M., RA Ruzhnikov M.R.Z., Kutsche K., Dolphin A.C.; RT "Biallelic CACNA2D1 loss-of-function variants cause early-onset RT developmental epileptic encephalopathy."; RL Brain 145:2721-2729(2022). CC -!- FUNCTION: The alpha-2/delta subunit of voltage-dependent calcium CC channels regulates calcium current density and activation/inactivation CC kinetics of the calcium channel (PubMed:35293990). Plays an important CC role in excitation-contraction coupling (By similarity). {ECO:0000250, CC ECO:0000269|PubMed:35293990}. CC -!- SUBUNIT: Dimer formed of alpha-2-1 and delta-1 chains; disulfide- CC linked. Voltage-dependent calcium channels are multisubunit complexes, CC consisting of alpha-1 (CACNA1), alpha-2 (CACNA2D), beta (CACNB) and CC delta (CACNA2D) subunits in a 1:1:1:1 ratio (By similarity). CC {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I CC membrane protein {ECO:0000305}. Cell membrane CC {ECO:0000269|PubMed:35293990}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=5; CC Name=1; Synonyms=Alpha-2a; CC IsoId=P54289-1; Sequence=Displayed; CC Name=2; Synonyms=Alpha-2b; CC IsoId=P54289-2; Sequence=VSP_038348, VSP_038350; CC Name=3; Synonyms=Alpha-2c; CC IsoId=P54289-3; Sequence=VSP_038349, VSP_038350; CC Name=4; Synonyms=Alpha-2d; CC IsoId=P54289-4; Sequence=VSP_038349; CC Name=5; Synonyms=Alpha-2e; CC IsoId=P54289-5; Sequence=VSP_038348; CC -!- TISSUE SPECIFICITY: Isoform 1 is expressed in skeletal muscle. Isoform CC 2 is expressed in the central nervous system. Isoform 2, isoform 4 and CC isoform 5 are expressed in neuroblastoma cells. Isoform 3, isoform 4 CC and isoform 5 are expressed in the aorta. {ECO:0000269|PubMed:1309651, CC ECO:0000269|PubMed:8107964}. CC -!- DOMAIN: The MIDAS-like motif in the VWFA domain binds divalent metal CC cations and is required to promote trafficking of the alpha-1 (CACNA1) CC subunit to the plasma membrane by an integrin-like switch. CC {ECO:0000250}. CC -!- PTM: Proteolytically processed into subunits alpha-2-1 and delta-1 that CC are disulfide-linked. {ECO:0000250}. CC -!- DISEASE: Developmental and epileptic encephalopathy 110 (DEE110) CC [MIM:620149]: A form of epileptic encephalopathy, a heterogeneous group CC of early-onset epilepsies characterized by refractory seizures, CC neurodevelopmental impairment, and poor prognosis. Development is CC normal prior to seizure onset, after which cognitive and motor delays CC become apparent. DEE110 is an autosomal recessive form characterized by CC profound global developmental delay and hypotonia apparent in infancy CC followed by onset of seizures in the first months or years of life. CC {ECO:0000269|PubMed:35293990}. Note=The disease is caused by variants CC affecting the gene represented in this entry. CC -!- MISCELLANEOUS: Binds gabapentin, an antiepileptic drug. CC -!- SIMILARITY: Belongs to the calcium channel subunit alpha-2/delta CC family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M76559; AAA51903.1; -; mRNA. DR EMBL; CH471091; EAW76990.1; -; Genomic_DNA. DR EMBL; BC117468; AAI17469.1; -; mRNA. DR EMBL; BC117470; AAI17471.1; -; mRNA. DR CCDS; CCDS5598.1; -. [P54289-2] DR CCDS; CCDS94135.1; -. [P54289-1] DR PIR; JH0565; JH0565. DR RefSeq; NP_000713.2; NM_000722.3. [P54289-2] DR RefSeq; XP_005250627.1; XM_005250570.2. DR RefSeq; XP_005250629.1; XM_005250572.2. [P54289-3] DR RefSeq; XP_005250630.1; XM_005250573.2. [P54289-5] DR RefSeq; XP_005250631.1; XM_005250574.2. [P54289-4] DR PDB; 7MIX; EM; 3.00 A; D=1-1103. DR PDB; 7MIY; EM; 3.10 A; D=1-1103. DR PDB; 7UHF; EM; 3.10 A; D=1-1103. DR PDB; 7UHG; EM; 3.00 A; D=1-1103. DR PDB; 7VFS; EM; 2.80 A; B=1-1103. DR PDB; 7VFU; EM; 3.00 A; B=1-1103. DR PDB; 7VFV; EM; 3.00 A; B=1-1103. DR PDB; 7VFW; EM; 3.30 A; B=1-1103. DR PDB; 7XLQ; EM; 3.10 A; D=27-1103. DR PDB; 7YG5; EM; 3.00 A; D=1-1103. DR PDB; 8E59; EM; 3.10 A; D=1-1103. DR PDB; 8E5A; EM; 3.30 A; D=1-1103. DR PDB; 8E5B; EM; 3.30 A; D=1-1103. DR PDB; 8EPL; EM; 3.10 A; C=1-1103. DR PDB; 8EPM; EM; 3.10 A; C=1-1103. DR PDB; 8IF3; EM; 3.20 A; A=1-1103. DR PDB; 8IF4; EM; 3.20 A; A=1-1103. DR PDB; 8WE6; EM; 2.90 A; D=1-1103. DR PDB; 8WE7; EM; 3.20 A; D=1-1103. DR PDB; 8WE8; EM; 2.90 A; D=1-1103. DR PDB; 8WE9; EM; 3.00 A; D=1-1103. DR PDB; 8WEA; EM; 3.20 A; D=1-1103. DR PDBsum; 7MIX; -. DR PDBsum; 7MIY; -. DR PDBsum; 7UHF; -. DR PDBsum; 7UHG; -. DR PDBsum; 7VFS; -. DR PDBsum; 7VFU; -. DR PDBsum; 7VFV; -. DR PDBsum; 7VFW; -. DR PDBsum; 7XLQ; -. DR PDBsum; 7YG5; -. DR PDBsum; 8E59; -. DR PDBsum; 8E5A; -. DR PDBsum; 8E5B; -. DR PDBsum; 8EPL; -. DR PDBsum; 8EPM; -. DR PDBsum; 8IF3; -. DR PDBsum; 8IF4; -. DR PDBsum; 8WE6; -. DR PDBsum; 8WE7; -. DR PDBsum; 8WE8; -. DR PDBsum; 8WE9; -. DR PDBsum; 8WEA; -. DR AlphaFoldDB; P54289; -. DR EMDB; EMD-23867; -. DR EMDB; EMD-23868; -. DR EMDB; EMD-26513; -. DR EMDB; EMD-26514; -. DR EMDB; EMD-27907; -. DR EMDB; EMD-27908; -. DR EMDB; EMD-27909; -. DR EMDB; EMD-28529; -. DR EMDB; EMD-28530; -. DR EMDB; EMD-31958; -. DR EMDB; EMD-31959; -. DR EMDB; EMD-31960; -. DR EMDB; EMD-31961; -. DR EMDB; EMD-33285; -. DR EMDB; EMD-33808; -. DR EMDB; EMD-35399; -. DR EMDB; EMD-35400; -. DR SMR; P54289; -. DR BioGRID; 107235; 83. DR ComplexPortal; CPX-3192; Skeletal muscle VGCC complex. DR ComplexPortal; CPX-3195; Cardiac muscle voltage-gated calcium channel complex. DR CORUM; P54289; -. DR IntAct; P54289; 36. DR STRING; 9606.ENSP00000349320; -. DR BindingDB; P54289; -. DR ChEMBL; CHEMBL1919; -. DR DrugBank; DB13746; Bioallethrin. DR DrugBank; DB11148; Butamben. DR DrugBank; DB04838; Cyclandelate. DR DrugBank; DB09235; Efonidipine. DR DrugBank; DB00228; Enflurane. DR DrugBank; DB00153; Ergocalciferol. DR DrugBank; DB01023; Felodipine. DR DrugBank; DB00996; Gabapentin. DR DrugBank; DB08872; Gabapentin enacarbil. DR DrugBank; DB00308; Ibutilide. DR DrugBank; DB00270; Isradipine. DR DrugBank; DB00622; Nicardipine. DR DrugBank; DB06712; Nilvadipine. DR DrugBank; DB00401; Nisoldipine. DR DrugBank; DB01054; Nitrendipine. DR DrugBank; DB00230; Pregabalin. DR DrugBank; DB00421; Spironolactone. DR DrugBank; DB00661; Verapamil. DR DrugCentral; P54289; -. DR TCDB; 8.A.18.1.1; the ca(2+) channel auxiliary subunit Alpha2Delta types 1-4 (cca-Alpha2Delta) family. DR GlyConnect; 1895; 24 N-Linked glycans (7 sites). DR GlyCosmos; P54289; 17 sites, 25 glycans. DR GlyGen; P54289; 17 sites, 25 N-linked glycans (7 sites). DR iPTMnet; P54289; -. DR PhosphoSitePlus; P54289; -. DR SwissPalm; P54289; -. DR BioMuta; CACNA2D1; -. DR DMDM; 262527579; -. DR EPD; P54289; -. DR jPOST; P54289; -. DR MassIVE; P54289; -. DR MaxQB; P54289; -. DR PaxDb; 9606-ENSP00000349320; -. DR PeptideAtlas; P54289; -. DR ProteomicsDB; 56675; -. [P54289-1] DR ProteomicsDB; 56676; -. [P54289-2] DR ProteomicsDB; 56677; -. [P54289-3] DR ProteomicsDB; 56678; -. [P54289-4] DR ProteomicsDB; 56679; -. [P54289-5] DR Pumba; P54289; -. DR Antibodypedia; 2200; 308 antibodies from 35 providers. DR DNASU; 781; -. DR Ensembl; ENST00000356860.8; ENSP00000349320.3; ENSG00000153956.17. [P54289-2] DR Ensembl; ENST00000443883.2; ENSP00000409374.2; ENSG00000153956.17. [P54289-1] DR GeneID; 781; -. DR KEGG; hsa:781; -. DR MANE-Select; ENST00000356860.8; ENSP00000349320.3; NM_000722.4; NP_000713.2. [P54289-2] DR UCSC; uc003uhr.2; human. [P54289-1] DR AGR; HGNC:1399; -. DR CTD; 781; -. DR DisGeNET; 781; -. DR GeneCards; CACNA2D1; -. DR GeneReviews; CACNA2D1; -. DR HGNC; HGNC:1399; CACNA2D1. DR HPA; ENSG00000153956; Tissue enhanced (skeletal muscle, tongue). DR MalaCards; CACNA2D1; -. DR MIM; 114204; gene. DR MIM; 620149; phenotype. DR neXtProt; NX_P54289; -. DR OpenTargets; ENSG00000153956; -. DR Orphanet; 130; Brugada syndrome. DR Orphanet; 51083; Familial short QT syndrome. DR Orphanet; 442835; Non-specific early-onset epileptic encephalopathy. DR PharmGKB; PA86; -. DR VEuPathDB; HostDB:ENSG00000153956; -. DR eggNOG; KOG2353; Eukaryota. DR GeneTree; ENSGT00940000155209; -. DR HOGENOM; CLU_004660_0_0_1; -. DR InParanoid; P54289; -. DR OMA; CLWPMLG; -. DR OrthoDB; 2971287at2759; -. DR PhylomeDB; P54289; -. DR TreeFam; TF315824; -. DR PathwayCommons; P54289; -. DR SignaLink; P54289; -. DR BioGRID-ORCS; 781; 9 hits in 1156 CRISPR screens. DR ChiTaRS; CACNA2D1; human. DR GeneWiki; CACNA2D1; -. DR GenomeRNAi; 781; -. DR Pharos; P54289; Tclin. DR PRO; PR:P54289; -. DR Proteomes; UP000005640; Chromosome 7. DR RNAct; P54289; Protein. DR Bgee; ENSG00000153956; Expressed in biceps brachii and 186 other cell types or tissues. DR ExpressionAtlas; P54289; baseline and differential. DR GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB. DR GO; GO:1990454; C:L-type voltage-gated calcium channel complex; IDA:BHF-UCL. DR GO; GO:0098992; C:neuronal dense core vesicle; IEA:Ensembl. DR GO; GO:0005886; C:plasma membrane; IDA:UniProtKB. DR GO; GO:0016529; C:sarcoplasmic reticulum; IEA:Ensembl. DR GO; GO:0005891; C:voltage-gated calcium channel complex; IDA:UniProtKB. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0005245; F:voltage-gated calcium channel activity; IDA:BHF-UCL. DR GO; GO:0098703; P:calcium ion import across plasma membrane; ISS:BHF-UCL. DR GO; GO:0061577; P:calcium ion transmembrane transport via high voltage-gated calcium channel; ISS:BHF-UCL. DR GO; GO:0006816; P:calcium ion transport; IDA:UniProtKB. DR GO; GO:0060402; P:calcium ion transport into cytosol; ISS:BHF-UCL. DR GO; GO:0086002; P:cardiac muscle cell action potential involved in contraction; IMP:BHF-UCL. DR GO; GO:1904646; P:cellular response to amyloid-beta; IGI:ARUK-UCL. DR GO; GO:0086048; P:membrane depolarization during bundle of His cell action potential; IMP:BHF-UCL. DR GO; GO:1901843; P:positive regulation of high voltage-gated calcium channel activity; ISS:BHF-UCL. DR GO; GO:1902514; P:regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; IGI:ARUK-UCL. DR GO; GO:0051924; P:regulation of calcium ion transport; IDA:BHF-UCL. DR GO; GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL. DR GO; GO:0098903; P:regulation of membrane repolarization during action potential; ISS:BHF-UCL. DR GO; GO:0060307; P:regulation of ventricular cardiac muscle cell membrane repolarization; IMP:BHF-UCL. DR CDD; cd18774; PDC2_HK_sensor; 1. DR CDD; cd01463; vWA_VGCC_like; 1. DR Gene3D; 3.30.450.20; PAS domain; 1. DR Gene3D; 3.40.50.410; von Willebrand factor, type A domain; 1. DR InterPro; IPR013680; VDCC_a2/dsu. DR InterPro; IPR013608; VWA_N. DR InterPro; IPR002035; VWF_A. DR InterPro; IPR036465; vWFA_dom_sf. DR PANTHER; PTHR10166; VOLTAGE-DEPENDENT CALCIUM CHANNEL SUBUNIT ALPHA-2/DELTA-RELATED; 1. DR PANTHER; PTHR10166:SF6; VOLTAGE-DEPENDENT CALCIUM CHANNEL SUBUNIT ALPHA-2_DELTA-1; 1. DR Pfam; PF08473; VGCC_alpha2; 1. DR Pfam; PF00092; VWA; 1. DR Pfam; PF08399; VWA_N; 1. DR SMART; SM00327; VWA; 1. DR SUPFAM; SSF53300; vWA-like; 1. DR PROSITE; PS50234; VWFA; 1. DR Genevisible; P54289; HS. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; Calcium; Calcium channel; KW Calcium transport; Cell membrane; Disease variant; Disulfide bond; KW Epilepsy; Glycoprotein; Intellectual disability; Ion channel; KW Ion transport; Membrane; Metal-binding; Phosphoprotein; Reference proteome; KW Signal; Transmembrane; Transmembrane helix; Transport; KW Voltage-gated channel. FT SIGNAL 1..24 FT /evidence="ECO:0000255" FT CHAIN 25..1103 FT /note="Voltage-dependent calcium channel subunit alpha- FT 2/delta-1" FT /id="PRO_0000304633" FT CHAIN 25..956 FT /note="Voltage-dependent calcium channel subunit alpha-2-1" FT /evidence="ECO:0000250" FT /id="PRO_0000005001" FT CHAIN 957..1103 FT /note="Voltage-dependent calcium channel subunit delta-1" FT /evidence="ECO:0000250" FT /id="PRO_0000005002" FT TOPO_DOM 25..1073 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 1074..1094 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 1095..1103 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT DOMAIN 253..430 FT /note="VWFA" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00219" FT DOMAIN 446..556 FT /note="Cache" FT MOTIF 259..263 FT /note="MIDAS-like motif" FT BINDING 259 FT /ligand="a divalent metal cation" FT /ligand_id="ChEBI:CHEBI:60240" FT /evidence="ECO:0000250" FT BINDING 261 FT /ligand="a divalent metal cation" FT /ligand_id="ChEBI:CHEBI:60240" FT /evidence="ECO:0000250" FT BINDING 263 FT /ligand="a divalent metal cation" FT /ligand_id="ChEBI:CHEBI:60240" FT /evidence="ECO:0000250" FT MOD_RES 119 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P54290" FT CARBOHYD 92 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:34234349, FT ECO:0007744|PDB:7MIX, ECO:0007744|PDB:7MIY" FT CARBOHYD 136 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 184 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:34234349, FT ECO:0007744|PDB:7MIX, ECO:0007744|PDB:7MIY" FT CARBOHYD 324 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 348 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:34234349, FT ECO:0007744|PDB:7MIX, ECO:0007744|PDB:7MIY" FT CARBOHYD 468 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:34234349, FT ECO:0007744|PDB:7MIX, ECO:0007744|PDB:7MIY" FT CARBOHYD 475 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 604 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 613 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:34234349, FT ECO:0007744|PDB:7MIX, ECO:0007744|PDB:7MIY" FT CARBOHYD 675 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 781 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:34234349, FT ECO:0007744|PDB:7MIX, ECO:0007744|PDB:7MIY" FT CARBOHYD 824 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 888 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 895 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:34234349, FT ECO:0007744|PDB:7MIX, ECO:0007744|PDB:7MIY" FT CARBOHYD 985 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 998 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 404..1059 FT /note="Interchain (between alpha-2-1 and delta-1 chains)" FT VAR_SEQ 531..554 FT /note="Missing (in isoform 3 and isoform 4)" FT /evidence="ECO:0000303|PubMed:8107964" FT /id="VSP_038349" FT VAR_SEQ 531..549 FT /note="Missing (in isoform 2 and isoform 5)" FT /evidence="ECO:0000303|PubMed:1309651, FT ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:8107964" FT /id="VSP_038348" FT VAR_SEQ 644 FT /note="Y -> SKKGKMKD (in isoform 2 and isoform 3)" FT /evidence="ECO:0000303|PubMed:1309651, FT ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:8107964" FT /id="VSP_038350" FT VARIANT 209 FT /note="G -> D (in DEE110; does not promote calcium currents FT in transfected cells indicating loss of function in the FT positive regulation of voltage-gated calcium channel FT activity; severely decreased localization at the cell FT membrane; undergoes limited proteolytic cleavage)" FT /evidence="ECO:0000269|PubMed:35293990" FT /id="VAR_087875" FT VARIANT 1019 FT /note="E -> D (in dbSNP:rs9886043)" FT /id="VAR_053960" FT VARIANT 1057 FT /note="D -> A (in dbSNP:rs35131433)" FT /id="VAR_035047" FT CONFLICT 99 FT /note="R -> S (in Ref. 1; AAA51903)" FT /evidence="ECO:0000305" FT CONFLICT 386 FT /note="T -> R (in Ref. 1; AAA51903)" FT /evidence="ECO:0000305" FT CONFLICT 395 FT /note="D -> E (in Ref. 1; AAA51903)" FT /evidence="ECO:0000305" FT CONFLICT 635 FT /note="L -> I (in Ref. 4; no nucleotide entry)" FT /evidence="ECO:0000305" FT HELIX 30..52 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 54..63 FT /evidence="ECO:0007829|PDB:7VFS" FT TURN 64..66 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 67..72 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 75..109 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 118..120 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 122..126 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 135..137 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 142..144 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 150..152 FT /evidence="ECO:0007829|PDB:7VFS" FT TURN 153..156 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 157..163 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 165..167 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 170..172 FT /evidence="ECO:0007829|PDB:8IF4" FT STRAND 174..176 FT /evidence="ECO:0007829|PDB:8IF3" FT HELIX 177..185 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 187..198 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 206..210 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 215..220 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 227..229 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 238..240 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 242..247 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 253..258 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 262..264 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 267..280 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 288..303 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 312..323 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 333..344 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 356..362 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 370..376 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 377..379 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 382..391 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 397..404 FT /evidence="ECO:0007829|PDB:7VFS" FT TURN 405..407 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 409..413 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 416..418 FT /evidence="ECO:0007829|PDB:7MIX" FT HELIX 419..430 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 432..436 FT /evidence="ECO:0007829|PDB:7VFS" FT TURN 438..440 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 453..455 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 457..467 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 470..474 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 480..482 FT /evidence="ECO:0007829|PDB:8IF4" FT STRAND 483..493 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 494..498 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 504..506 FT /evidence="ECO:0007829|PDB:7UHF" FT STRAND 511..515 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 517..520 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 561..564 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 570..579 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 584..593 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 600..611 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 613..616 FT /evidence="ECO:0007829|PDB:7MIX" FT STRAND 618..624 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 625..627 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 628..633 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 637..639 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 640..646 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 650..652 FT /evidence="ECO:0007829|PDB:7MIX" FT TURN 653..655 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 658..661 FT /evidence="ECO:0007829|PDB:7MIX" FT STRAND 667..670 FT /evidence="ECO:0007829|PDB:7MIX" FT HELIX 676..688 FT /evidence="ECO:0007829|PDB:7VFS" FT TURN 694..696 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 699..716 FT /evidence="ECO:0007829|PDB:7VFS" FT TURN 717..723 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 727..736 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 739..741 FT /evidence="ECO:0007829|PDB:8IF4" FT STRAND 743..748 FT /evidence="ECO:0007829|PDB:7VFS" FT TURN 749..751 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 758..760 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 762..769 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 771..776 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 780..785 FT /evidence="ECO:0007829|PDB:7MIX" FT TURN 788..790 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 792..797 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 800..804 FT /evidence="ECO:0007829|PDB:7MIX" FT STRAND 805..807 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 810..816 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 818..827 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 828..830 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 851..853 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 855..857 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 858..866 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 868..870 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 875..878 FT /evidence="ECO:0007829|PDB:7VFS" FT HELIX 880..888 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 891..904 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 972..983 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 989..994 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 997..999 FT /evidence="ECO:0007829|PDB:7UHG" FT STRAND 1001..1007 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 1014..1016 FT /evidence="ECO:0007829|PDB:7VFS" FT TURN 1021..1023 FT /evidence="ECO:0007829|PDB:7MIX" FT STRAND 1036..1038 FT /evidence="ECO:0007829|PDB:7MIX" FT HELIX 1043..1046 FT /evidence="ECO:0007829|PDB:7VFS" FT STRAND 1047..1049 FT /evidence="ECO:0007829|PDB:7VFS" FT TURN 1072..1074 FT /evidence="ECO:0007829|PDB:7MIX" SQ SEQUENCE 1103 AA; 124568 MW; 0749685DE9DB0700 CRC64; MAAGCLLALT LTLFQSLLIG PSSEEPFPSA VTIKSWVDKM QEDLVTLAKT ASGVNQLVDI YEKYQDLYTV EPNNARQLVE IAARDIEKLL SNRSKALVRL ALEAEKVQAA HQWREDFASN EVVYYNAKDD LDPEKNDSEP GSQRIKPVFI EDANFGRQIS YQHAAVHIPT DIYEGSTIVL NELNWTSALD EVFKKNREED PSLLWQVFGS ATGLARYYPA SPWVDNSRTP NKIDLYDVRR RPWYIQGAAS PKDMLILVDV SGSVSGLTLK LIRTSVSEML ETLSDDDFVN VASFNSNAQD VSCFQHLVQA NVRNKKVLKD AVNNITAKGI TDYKKGFSFA FEQLLNYNVS RANCNKIIML FTDGGEERAQ EIFNKYNKDK KVRVFTFSVG QHNYDRGPIQ WMACENKGYY YEIPSIGAIR INTQEYLDVL GRPMVLAGDK AKQVQWTNVY LDALELGLVI TGTLPVFNIT GQFENKTNLK NQLILGVMGV DVSLEDIKRL TPRFTLCPNG YYFAIDPNGY VLLHPNLQPK PIGVGIPTIN LRKRRPNIQN PKSQEPVTLD FLDAELENDI KVEIRNKMID GESGEKTFRT LVKSQDERYI DKGNRTYTWT PVNGTDYSLA LVLPTYSFYY IKAKLEETIT QARYSETLKP DNFEESGYTF IAPRDYCNDL KISDNNTEFL LNFNEFIDRK TPNNPSCNAD LINRVLLDAG FTNELVQNYW SKQKNIKGVK ARFVVTDGGI TRVYPKEAGE NWQENPETYE DSFYKRSLDN DNYVFTAPYF NKSGPGAYES GIMVSKAVEI YIQGKLLKPA VVGIKIDVNS WIENFTKTSI RDPCAGPVCD CKRNSDVMDC VILDDGGFLL MANHDDYTNQ IGRFFGEIDP SLMRHLVNIS VYAFNKSYDY QSVCEPGAAP KQGAGHRSAY VPSVADILQI GWWATAAAWS ILQQFLLSLT FPRLLEAVEM EDDDFTASLS KQSCITEQTQ YFFDNDSKSF SGVLDCGNCS RIFHGEKLMN TNLIFIMVES KGTCPCDTRL LIQAEQTSDG PNPCDMVKQP RYRKGPDVCF DNNVLEDYTD CGGVSGLNPS LWYIIGIQFL LLWLVSGSTH RLL //